ALB and nasopharyngeal carcinoma: In a large Chinese cohort of 858 NPC patients receiving concurrent CRT, age > 45 years, advanced T and N stage, and elevated platelet-to-albumin ratio (PAR) predicted inferior OS, while histology (98.5% Type III) did not.